Gilead gets Sovaldi patent approval in India despite opposition
10-05-2016
MSF urges Indian Patent Office to reject Gilead Sovaldi patent
02-03-2016
15-03-2016
pio3 / Shutterstock.com
Activist organisation Médecins Sans Frontières (MSF) has challenged Pfizer’s patent application covering the pneumococcal conjugate vaccine on the grounds that it is obvious.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Médecins Sans Frontières; Pfizer; Indian Patent Office; European Patent Office;